AME
77
2
SRE
49
2
MU
76
-3
EIX
56
-3
FTI
68
4
HCA
64
2
CMCSA
52
2
LUV
66
-4
WYNN
45
-3
NAVI
33
-7
CCI
38
2
BEN
55
-2
VMC
57
4
XYL
33
-2
FE
52
2
SPG
50
2
BF.B
35
-4
ADBE
55
-3
XRAY
25
-4
TRIP
50
-2
AME
77
2
SRE
49
2
MU
76
-3
EIX
56
-3
FTI
68
4
HCA
64
2
CMCSA
52
2
LUV
66
-4
WYNN
45
-3
NAVI
33
-7
CCI
38
2
BEN
55
-2
VMC
57
4
XYL
33
-2
FE
52
2
SPG
50
2
BF.B
35
-4
ADBE
55
-3
XRAY
25
-4
TRIP
50
-2
Financhill
Back

Goldman Sachs Access Treasury 0-1 Year ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
30

GBIL
Goldman Sachs Access Treasury 0-1 Year ETF

Last Price:
$100.21
Seasonality Move:
0.01%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.55
Seasonality Move:
-34.19%
Sell
30
Goldman Sachs Access Treasury 0-1 Year ETF (GBIL) is a Sell

Is Goldman Sachs Access Treasury 0-1 Year ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Access Treasury 0-1 Year ETF [GBIL] share price is $100.18. The Score for GBIL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • GBIL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GBIL Stock Price Chart

What is Goldman Sachs Access Treasury 0-1 Year ETF's stock price today?

  • The Goldman Sachs Access Treasury 0-1 Year ETF share price today is $100.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBIL is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GBIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 64.98 Buy
Chaikin Money Flow: 827258 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.01 - 100.15) Buy
Bollinger Bands (100): (99.97 - 100.15) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

GBIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.12 Buy
20-day SMA: 100.08 Buy
50-day SMA: 100.07 Buy
200-day SMA: 100.03 Buy
8-day EMA: 100.13 Buy
20-day EMA: 100.09 Buy
50-day EMA: 98.38 Buy
200-day EMA: 63.98 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Goldman Sachs Access Treasury 0-1 Year ETF Earnings Growth & GBIL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Goldman Sachs Access Treasury 0-1 Year ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):